IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $5,358,000 | +143.2% | 134,324 | +174.1% | 0.01% | +100.0% |
Q1 2021 | $2,203,000 | -30.4% | 49,000 | -12.5% | 0.00% | -25.0% |
Q4 2020 | $3,166,000 | +36.5% | 56,000 | +14.5% | 0.00% | 0.0% |
Q3 2020 | $2,320,000 | -22.7% | 48,900 | -3.9% | 0.00% | -20.0% |
Q2 2020 | $3,001,000 | +27.7% | 50,900 | +2.4% | 0.01% | 0.0% |
Q1 2020 | $2,350,000 | -15.8% | 49,700 | +7.6% | 0.01% | 0.0% |
Q4 2019 | $2,791,000 | -85.3% | 46,200 | -85.4% | 0.01% | -75.0% |
Q3 2019 | $18,932,000 | +95.7% | 316,000 | +110.0% | 0.02% | -4.8% |
Q2 2019 | $9,673,000 | +43.8% | 150,500 | +81.5% | 0.02% | +40.0% |
Q1 2019 | $6,729,000 | +127.9% | 82,900 | +51.8% | 0.02% | +114.3% |
Q4 2018 | $2,952,000 | +47.2% | 54,600 | +40.4% | 0.01% | +75.0% |
Q3 2018 | $2,006,000 | +23.8% | 38,900 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,621,000 | -5.5% | 38,900 | -48.6% | 0.00% | -42.9% |
Q2 2016 | $1,716,000 | -32.7% | 75,628 | +2.5% | 0.01% | -36.4% |
Q1 2016 | $2,550,000 | -0.1% | 73,800 | +79.1% | 0.01% | 0.0% |
Q4 2015 | $2,552,000 | – | 41,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |